Xlear says the move calls FTC’s authority to require clinical studies for non-pharmaceutical health products into question.

DOJ ASKS COURT TO DISMISS FTC-XLEAR LAWSUIT; Calls into Question FTC’s Authority to Require Clinical Studies for Non-Pharmaceutical Health Products ...